Your browser doesn't support javascript.
loading
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death.
Flanagan, Ken; Kumari, Romika; Miettinen, Juho J; Haney, Staci L; Varney, Michelle L; Williams, Jacob T; Majumder, Muntasir M; Suvela, Minna; Slipicevic, Ana; Lehmann, Fredrik; Nupponen, Nina N; Holstein, Sarah A; Heckman, Caroline A.
Afiliação
  • Flanagan K; Oncopeptides AB, Stockholm, Sweden.
  • Kumari R; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.
  • Miettinen JJ; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.
  • Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Varney ML; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Williams JT; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Majumder MM; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.
  • Suvela M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.
  • Slipicevic A; Oncopeptides AB, Stockholm, Sweden.
  • Lehmann F; Oncopeptides AB, Stockholm, Sweden.
  • Nupponen NN; Oncopeptides AB, Stockholm, Sweden.
  • Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Heckman CA; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.
Hemasphere ; 6(3): e687, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35243210

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Hemasphere Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Hemasphere Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia